Significant progress and new insights have been gained in the 4 years since the first
Maastricht Consensus Report, necessitating an update of the original guidelines. To achieve …

Significant progress and new insights have been gained in the 4 years since the first
Maastricht Consensus Report, necessitating an update of the original guidelines. To achieve …

The occurrence of refractory Helicobacter pylori infection is increasing. When the bacteria
are not eradicated it means that the antibiotics have not reached the gastric mucosa at a …

Currently available Helicobacter pylori eradication therapies are considered very effective
and safe. The most recent eradication guidelines proposed in the Maastricht 2‐2000 …

Background: Guidelines on the management of Helicobacter pylori, which cover indications
for management and treatment strategies, were produced in 2000. Aims: To update the …

Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

Background Helicobacter pylori infection is still frequent in the community and all infected
subjects should be offered an eradication therapy. Nowadays physicians have to face the …

Helicobacter pylori is probably the most common bacterial infection worldwide and the
accepted cause of chronic active gastritis. It has a critical role in duodenal ulcer, where the …

Helicobacter pylori (H. pylori) plays a crucial role in the pathogenesis of chronic active
gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also …

At present we must consider ulcer disease an infectious disease and treat it accordingly (1,
2). Not eradicating Helicobacter pylori means withholding potential cure in an otherwise …